Observations on intravenous administration of lignocaine in patients with myocardial infarction.
Open Access
- 1 December 1978
- Vol. 40 (12) , 1371-1375
- https://doi.org/10.1136/hrt.40.12.1371
Abstract
Lignocaine was administered intravenously to 36 patients with acute myocardial infarction. A bolus of 100 mg followed by an infusion of 2 mg/minute failed to maintain plasma levels above 2 microgram/ml. A bolus of 100 mg followed by 4 mg/minute also failed to maintain satisfactory plasma concentrations during the first hour of therapy. A bolus of 75 mg was combined with an infusion of 10 mg/minute for 20 minutes followed by 1.5 mg/minute. Satisfactory plasma concentrations during the first hour were observed in 94 per cent of the estimations. No important adverse side effects occurred during the infusion of 10 mg/minute.This publication has 17 references indexed in Scilit:
- Lignocaine: a new technique for intravenous administration.Heart, 1977
- ANTIARRHYTHMIC ACTION OF LIGNOCAINE IN EARLY MYOCARDIAL INFARCTIONThe Lancet, 1977
- Logical approach to lignocaine therapy.BMJ, 1976
- The Clinical Pharmacology of Lidocaine as an Antiarrhythymic DrugCirculation, 1974
- Effect of lidocaine on “geting” mechanismAmerican Heart Journal, 1974
- Use of lidocaine by continuous infusionAmerican Heart Journal, 1974
- Antiarrhythmic Effectiveness of Intramuscular Lidocaine: Influence of Different Injection SitesThe Journal of Clinical Pharmacology, 1974
- Effect of Propranolol, Procainamide, and Lidocaine on Ventricular Automaticity and Reentry in Experimental Myocardial InfarctionCirculation, 1972
- Antiarrhythmic Prophylaxis in Ambulatory Patients With Coronary Heart DiseaseArchives of internal medicine (1960), 1972
- Cardiovascular effects of infusion of lidocaine on patients with heart diseaseThe American Journal of Cardiology, 1969